ANGIODYNAMICS INC Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Angiodynamics Inc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2011 to Q3 2024.
  • Angiodynamics Inc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending August 31, 2024 was $39.6M, a 20.5% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $39.6M -$10.2M -20.5% Aug 31, 2024 10-Q 2024-10-03
Q2 2024 $43.6M -$9.22M -17.4% May 31, 2024 10-Q 2024-10-03
Q1 2024 $49.5M -$1.42M -2.78% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 $51.6M -$1.25M -2.36% Nov 30, 2023 10-Q 2024-01-08
Q3 2023 $49.8M -$3.83M -7.15% Aug 31, 2023 10-Q 2023-10-05
Q2 2023 $52.8M +$522K +1% May 31, 2023 10-K 2024-07-25
Q1 2023 $50.9M +$9.08M +21.7% Feb 28, 2023 10-Q 2023-03-31
Q4 2022 $52.9M +$14.6M +38.3% Nov 30, 2022 10-Q 2023-01-06
Q3 2022 $53.6M +$18.2M +51.3% Aug 31, 2022 10-Q 2022-10-11
Q2 2022 $52.3M +$16.9M +47.7% May 31, 2022 10-K 2023-08-03
Q1 2022 $41.8M +$8.64M +26% Feb 28, 2022 10-Q 2022-04-07
Q4 2021 $38.2M +$4.6M +13.7% Nov 30, 2021 10-Q 2022-01-07
Q3 2021 $35.4M +$1.83M +5.44% Aug 31, 2021 10-Q 2021-09-30
Q2 2021 $35.4M +$4.14M +13.2% May 31, 2021 10-K 2022-07-22
Q1 2021 $33.2M -$2.45M -6.87% Feb 28, 2021 10-Q 2021-03-31
Q4 2020 $33.6M -$390K -1.15% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 $33.6M +$1.05M +3.23% Aug 31, 2020 10-Q 2020-10-07
Q2 2020 $31.3M -$12.3M -28.3% May 31, 2020 10-K 2021-07-27
Q1 2020 $35.6M -$8.59M -19.4% Feb 29, 2020 10-Q 2020-04-08
Q4 2019 $34M -$9.38M -21.6% Nov 30, 2019 10-Q 2020-01-08
Q3 2019 $32.5M -$7.62M -19% Aug 31, 2019 10-Q 2019-10-04
Q2 2019 $43.6M +$4.18M +10.6% May 31, 2019 10-K 2020-08-10
Q1 2019 $44.2M +$2.38M +5.69% Feb 28, 2019 10-Q 2019-04-02
Q4 2018 $43.4M +$1.3M +3.09% Nov 30, 2018 10-Q 2019-01-07
Q3 2018 $40.2M -$1.12M -2.71% Aug 31, 2018 10-Q 2018-10-01
Q2 2018 $39.4M -$5.12M -11.5% May 31, 2018 10-K 2019-07-25
Q1 2018 $41.8M -$4.48M -9.67% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 $42.1M -$8.1M -16.1% Nov 30, 2017 10-Q 2018-01-05
Q3 2017 $41.3M -$8.84M -17.6% Aug 31, 2017 10-Q 2017-09-29
Q2 2017 $44.5M -$8.34M -15.8% May 31, 2017 10-K 2018-07-23
Q1 2017 $46.3M -$8.14M -15% Feb 28, 2017 10-Q 2017-04-03
Q4 2016 $50.2M -$2.95M -5.55% Nov 30, 2016 10-Q 2017-01-06
Q3 2016 $50.1M -$2.3M -4.39% Aug 31, 2016 10-Q 2016-10-05
Q2 2016 $52.9M -$5.56M -9.52% May 31, 2016 10-K 2017-08-04
Q1 2016 $54.4M -$3.32M -5.75% Feb 29, 2016 10-Q 2016-04-11
Q4 2015 $53.1M -$5.44M -9.29% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 $52.4M -$3.6M -6.43% Aug 31, 2015 10-Q 2015-10-08
Q2 2015 $58.4M -$3.54M -5.71% May 31, 2015 10-K 2016-08-01
Q1 2015 $57.8M +$44K +0.08% Feb 28, 2015 10-Q 2015-04-09
Q4 2014 $58.6M +$10.2M +21% Nov 30, 2014 10-Q 2015-01-09
Q3 2014 $56M +$9.47M +20.3% Aug 31, 2014 10-Q 2014-10-15
Q2 2014 $62M +$14.3M +30% May 31, 2014 10-K 2015-08-10
Q1 2014 $57.7M +$12.6M +28% Feb 28, 2014 10-Q 2014-04-09
Q4 2013 $48.4M +$1.32M +2.8% Nov 30, 2013 10-Q 2014-01-09
Q3 2013 $46.6M +$1.13M +2.49% Aug 31, 2013 10-Q 2013-10-10
Q2 2013 $47.7M +$778K +1.66% May 31, 2013 10-K/A 2015-01-12
Q1 2013 $45.1M +$18.4M +68.8% Feb 28, 2013 10-Q 2013-04-09
Q4 2012 $47.1M +$15.6M +49.7% Nov 30, 2012 10-Q 2013-01-09
Q3 2012 $45.4M +$19.1M +72.3% Aug 31, 2012 10-Q/A 2012-11-09
Q2 2012 $46.9M +$19.9M +73.6% May 31, 2012 10-K/A 2015-01-12
Q1 2012 $26.7M Feb 29, 2012 10-Q 2012-04-09
Q4 2011 $31.5M Nov 30, 2011 10-Q 2012-01-05
Q3 2011 $26.4M Aug 31, 2011 10-Q 2011-10-11
Q2 2011 $27M May 31, 2011 10-K/A 2015-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.